Balyasny Asset Management’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | – | Sell |
-37,376
| Closed | -$2.17M | – | 1598 |
|
2019
Q2 | $2.17M | Buy |
37,376
+19,342
| +107% | +$1.13M | 0.01% | 720 |
|
2019
Q1 | $1.26M | Sell |
18,034
-1,187
| -6% | -$83.1K | 0.01% | 855 |
|
2018
Q4 | $1.24M | Buy |
+19,221
| New | +$1.24M | 0.01% | 747 |
|
2017
Q4 | – | Sell |
-10,000
| Closed | -$321K | – | 2126 |
|
2017
Q3 | $321K | Buy |
+10,000
| New | +$321K | ﹤0.01% | 1303 |
|
2016
Q1 | – | Sell |
-14,770
| Closed | -$520K | – | 1419 |
|
2015
Q4 | $520K | Buy |
+14,770
| New | +$520K | ﹤0.01% | 687 |
|